Author:
Asiimwe Stephen B.,Farrell Meagan,Kobayashi Lindsay C.,Manne-Goehler Jen,Kahn Kathleen,Tollman Stephen M.,Kabudula Chodziwadziwa Whiteson,Gómez-Olivé F. Xavier,Wagner Ryan G.,Montana Livia,Berkman Lisa F.,Glymour M. Maria,Bärnighausen Till
Abstract
AbstractPrevious clinical studies have reported adverse cognitive outcomes for people living with HIV (PLWH), but there are no population-based studies comparing cognitive function between older PLWH and comparators without HIV in sub-Saharan Africa. We analyzed baseline data of 40 + years-old participants in “Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa” (HAALSI) cohort. We measured cognition using a battery of conventional instruments assessing orientation, immediate- and delayed-recall, and numeracy (N = 4560), and the Oxford Cognitive Screen [OCS]-Plus, a novel instrument for low-literacy populations, assessing memory, language, visual-spatial ability, and executive functioning (N = 1997). Linear regression models comparing cognitive scores between participants with and without HIV were adjusted for sex, education, age, country of birth, father’s occupation, ever-consumed alcohol, and asset index. PLWH scored on average 0.06 (95% CI 0.01–0.12) standard deviation (SD) units higher on the conventional cognitive function measure and 0.02 (95% CI − 0.07 to 0.04) SD units lower on the OCS-Plus measure than HIV-negative participants. We found higher cognitive function scores for PLWH compared to people without HIV when using a conventional measure of cognitive function but not when using a novel instrument for low-literacy settings.
Funder
National Institute of Allergy and Infectious Diseases
National Institute on Aging
The University of Witwatersrand, Medical Research Council, South Africa, and The Wellcome Trust, UK
Alexander von Humboldt Foundation
National Institute of Child Health and Human Development
Forgaty International Center
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. McArthur, J. C., Steiner, J., Sacktor, N. & Nath, A. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol. 67(6), 699–714 (2010).
2. Eggers, C. et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol. 264(8), 1715–1727 (2017).
3. Robertson, K. R. et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 21(14), 1915–1921 (2007).
4. Sheppard, D. P. et al. Does older age confer an increased risk of incident neurocognitive disorders among persons living with HIV disease?. Clin Neuropsychol. 29(5), 656–677 (2015).
5. Mogambery, J. C., Dawood, H., Wilson, D. & Moodley, A. HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: a prospective study. S. Afr. J. HIV Med. 18(1), 732 (2017).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献